Based on their success treating C. difficile, drugmakers are using different strategies to develop microbiome cancer therapies, including using genomics tools to home in on patient-specific strategies.
Real-World Study Examines Genomic Profiling Challenges for Patients With Cancers of Unknown Primary
The researchers found that more than half of patients with CUP did not have sufficient tissue to undergo genomic profiling.
In Brief This Week: Clarity Pharmaceuticals, Regenxbio, Rocket Pharmaceuticals, Eisai, AstraZeneca
News items for the week of May 22, 2023.
Bristol Myers Squibb Eyeing CLL, SLL as Additional Breyanzi Indications After Positive Readout
Around 18 percent of patients in a Phase I/II trial with aggressive, treatment-refractory forms of leukemia had complete responses on the CAR T-cell therapy.
WashU Researchers Studying Amyloid-Lowering Insomnia Drug's Effect on Alzheimer's Development
Investigators will assess whether a drug already approved for insomnia decreases the rate of amyloid accumulation in patients at risk for developing Alzheimer's.
May 24, 2023
PTC Therapeutics Cuts Multiple Gene Therapy Programs
May 22, 2023